Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo

Gene Therapy

Volumn 6, Issue 10, 1999, Pages 1679-1684

  Dumas, T D ^a   McLaughlin, J R ^a   Ho, D Y ^b   Meier, T J ^c   Sapolsky, R M ^a  

^a STANFORD UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c XAVIER UNIVERSITY   (United States)

Author keywords

Calbindin D(28k); Dentate gyrus; Herpes simplex; Hippocampus; Infection; Synaptic transmission

Indexed keywords

CALBINDIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN NECROSIS; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENTATE GYRUS; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; GENE TARGETING; GRANULE CELL; HERPES SIMPLEX VIRUS; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOSSY FIBER; NERVE TRACT; NERVOUS SYSTEM; NEUROPROTECTION; NONHUMAN; PERFORANT NERVE TRACT; PHYSIOLOGY; PRIORITY JOURNAL; RAT; REPORTER GENE; SURVIVAL; SYNAPTIC TRANSMISSION; VIRUS INFECTION;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DENTATE GYRUS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELPER VIRUSES; HERPESVIRUS 1, HUMAN; HIPPOCAMPUS; LAC OPERON; MALE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 0032827596     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300997     Document Type: Article

References (50)

1. Ho DY et al. Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. J Neurochem 1995; 65: 842-850.
2. Lawrence MS, Ho DY, Dash R, Sapolsky RM. A Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc Natl Acad Sci USA 1995; 92: 7247-7251.
3. Dash R, Lawrence M, Ho D, Sapolsky R. A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin. Exp Neural 1996; 137: 43-48.
4. Lawrence MS et al. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J Cereb Blood Flouw Metab 1996; 16: 181-185.
5. Kindy M et al. Adenoviral vectors in ischemic injury. In: Krieglstein J (ed). Pharmacology of Cerebral Ischemia. Medpharm: Stuttgart, 1996, pp 111 -122.
6. Meier TJ, Ho DY, Sapolsky RM. Increased expression of calbindin D28k via herpes simplex virus amplicon vector decreases calcium ion mobilization and enhances neuronal survival after hypoglycemic challenge. J Neurochem 1997; 69: 1039-1047.
7. Meier TJ, Ho DY, Park TS, Sapolsky RM. Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide. J Neurochem 1998; 71: 1013-1023.
8. Fink SL, Chang LK, Ho DY, Sapolsky RM. Defective herpes simplex virus vectors expressing the rat brain stress-inducible heat shock protein 72 protect cultured neurons from severe heat shock. J Neurochem 1997; 68: 961-969.
9. Yenari MA et al. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol 1998; 44: 584-591.
10. Linnik MD, Zahos P, Geschwind MD, Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 1995; 26: 1670-1674; discussion 1675.
11. Jia WW et al. A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult. Brain Res Mol Brain Res 1996; 42: 350-353.
12. Lawrence MS et al. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 1996; 16: 486-496.
13. Lawrence MS et al. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab 1997; 17: 740-744.
14. Xu DG et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med 1997; 3: 997-1004.
15. Betz AL, Yang GY, Davidson BL. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 1995; 15: 547-551.
16. Hagan P et al. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats. Neurosci 1996; 75: 1033-1045.
17. Chiocca EA et al. Transfer and expression of the lacZ gene in rat brain neurons mediated by Herpes simplex virus mutants. New Biol 1990; 2: 739-746.
18. Dobson AT et al. A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons. Neuron 1990; 5: 353-360.
19. Geller AI, Keyomarski K, Bryan J, Pardee AB. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA 1990; 87: 8950-8954.
20. Kaplitt MG et al. Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol Cell Neurosci 1991; 2: 320-330.
21. Johnson PA et al. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 1992; 66: 2952-2965.
22. Johnson PA, Yoshida K, Gage FH, Friedmann T. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol Brain Res 1992; 12: 95-102.
23. Wood MJ et al. Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting. Exp Neurol 1994; 130: 127-140.
24. Ho DY et al. Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J Neurosci Met 1995; 57: 205-215.
25. Jia WW, Tan J, Redekop GJ, Goldie JH. Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytoma. J Neurosurg 1996; 85: 662-666.
26. During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 1994; 266: 1399-1403.
27. Bergold PJ, Casaccia-Bonnefil P, Zeng XL, Federoff HJ. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci USA 1993; 90: 6165-6169.
28. Ho DY, Mocarski ES, Sapolsky RM. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci USA 1993; 90: 3655-3659.
29. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
30. Howard MK et al. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and 1CP34.5. Gene Therapy 1998; 5: 1137-1147.
31. Chard PS et al. Regulation of excitatory transmission at hippocampal synapses by calbindin D28k. Proc Natl Acad Sci USA 1995; 92: 5144-5148.
32. 3H-thymidine autoradiography. J Comp Neural 1980; 190: 87-114.
33. Fenwick M. The effect of herpes viruses on cellular macromolecular synthesis. Comp Virol 1984; 19: 359-390.
34. Heilbronn R, zur Hausen H. A subset of Herpes simplex virus replication genes induces DNA amplification within the host cell genome. J Virol 1989; 63: 3683-3692.
35. Kwong AD, Frenkel N. The Herpes simplex virus virion host shutoff function. J Virol 1989; 63: 4834-4839.
36. Cantin EM, Hinton DR, Chen J, Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 1995; 69: 4898-4905.
37. Halford WP, Gebhardt BM, Carr DJ. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 1996; 157: 3542-3549.
38. Liu T, Tang Q, Hendricks RL. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 1996; 70: 264-271.
39. 2+ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 1994; 266: 1-10.
40. Yu B, Shinnick-Gallagher P. Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons. J Pharmacol Exp Ther 1994; 271: 590-600.
41. Cunningham AJ et al. Interleukin-1 beta (IL-I beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 1996; 203: 17-20.
42. Coogan A, O'Connor JJ. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-I beta. NeuroRep 1997; 8: 2107-2110.
43. Li AJ et al. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 1997; 748: 30-38.
44. Murray CA, Lynch MA. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age-and stress-induced impairments in long-term potentiation. J Neurosci 1998; 18: 2974-2981.
45. Pauli S, Linthorst AC, Reul JM. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat. Eur J Neurosci 1998; 10: 868-878.
46. Song S et al. Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci 1998; 18: 4119-4132.
47. Wu L-G, Saggau P. Presynaptic calcium is increased during normal synaptic transmission and paired-pulse facilitation but not in long-term potentiation in area CA1 of hippocampus. J Neurosci 1994; 14: 645-654.
48. Ho DY. Amplicon-based herpes simplex virus vectors. Metab Cell Biol 1994; 43: 191-210.
49. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type I in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558-570.
50. Creager R, Dunwiddie T, Lynch G. Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. J Physiol 1980; 299: 409-424.